Cargando…

Is neutrophilic inflammation treatable in COVID-19?

Detalles Bibliográficos
Autores principales:	Conrad, Catharina, Looney, Mark R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442495/ https://www.ncbi.nlm.nih.gov/pubmed/36075244 http://dx.doi.org/10.1016/S2213-2600(22)00293-4

Ejemplares similares

Tissue damage from neutrophil-induced oxidative stress in COVID-19
por: Laforge, Mireille, et al.
Publicado: (2020)

Off-label therapy targeting pathogenic inflammation in COVID-19
por: Romani, Luigina, et al.
Publicado: (2020)

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
por: Saini, Kamal S., et al.
Publicado: (2020)

Long COVID: systemic inflammation and obesity as therapeutic targets
por: Florencio, Lidiane L, et al.
Publicado: (2022)

Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
por: Cavanagh, Gregory, et al.
Publicado: (2020)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Low density, high impact? Neutrophil changes in obesity and bariatric surgery
por: Roberts, Cullen F., et al.
Publicado: (2022)

What are the key pediatric public policy priorities as the COVID-19 pandemic persists?
por: Schleiss, Mark R., et al.
Publicado: (2023)

Type 2 alveolar epithelial cell-derived circulating extracellular vesicle-encapsulated surfactant protein C as a mediator of cardiac inflammation in COVID-19
por: Rudiansyah, Mohammad, et al.
Publicado: (2022)

Increased neutrophil infiltration as a body-wide effect in pancreatic cancer development
por: Chen, Ru, et al.
Publicado: (2022)

ApoNETosis: discovery of a novel form of neutrophil death with concomitant apoptosis and NETosis
por: Azzouz, Dhia, et al.
Publicado: (2018)

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
por: Park, Jay J H, et al.
Publicado: (2020)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

Rapid COVID-19 vaccine rollout: immense success but challenges ahead
por: Sandmann, Frank G, et al.
Publicado: (2022)

Treatable Mechanisms in Asthma
por: Cazzola, Mario, et al.
Publicado: (2021)

Treatable cerebellar ataxias()
por: K.P., Divya, et al.
Publicado: (2020)

Distinguishing the real from the hyperglycaemia: does COVID-19 induce diabetes?
por: Atkinson, Mark A, et al.
Publicado: (2021)

Neutrophil extracellular traps: from antimicrobial innate immunity to the development of chemotherapy-induced peripheral neuropathy
por: Koike, Haruki, et al.
Publicado: (2023)

Mechanism and disease implications of necroptosis and neuronal inflammation
por: Oliveira, Sara R., et al.
Publicado: (2018)

The urgent need for research coordination to advance knowledge on COVID-19 in children
por: Bourgeois, Florence T., et al.
Publicado: (2020)

Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
por: David, Benjamin, et al.
Publicado: (2021)

Advanced renal cell carcinoma and COVID-19 — a personal perspective
por: Ged, Yasser, et al.
Publicado: (2020)

How repeated influenza vaccination effects might apply to COVID-19 vaccines
por: Thompson, Mark G, et al.
Publicado: (2022)

Challenges in the interpretation and application of typical imaging features of COVID-19
por: Hammer, Mark M, et al.
Publicado: (2020)

Neutrophil Extracellular Traps (NETs): A New Therapeutic Target for Neuroinflammation and Microthrombosis After Subarachnoid Hemorrhage?
por: Zhou, Jiru, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on clinical research
por: Tuttle, Katherine R.
Publicado: (2020)

COVID-19 and the endocrine system: exploring the unexplored
por: Pal, R., et al.
Publicado: (2020)

Reduction in COVID-19-related mortality over time but disparities across population subgroups
por: Tenforde, Mark W, et al.
Publicado: (2023)

Leveraging the advances in HIV for COVID-19
por: McMahon, James H, et al.
Publicado: (2020)

Anticoagulation in COVID-19
por: Bradbury, Charlotte A, et al.
Publicado: (2022)

COVID-19 is not influenza
por: Petersen, Eskild
Publicado: (2021)

Worldwide physical activity trends since COVID-19 onset
por: Tison, Geoffrey H, et al.
Publicado: (2022)

Risk stratification of patients with COVID-19 in the community
por: Knight, Stephen R, et al.
Publicado: (2022)

The interplay between COVID-19 restrictions and vaccination
por: Wells, Chad R, et al.
Publicado: (2021)

COVID-19 and disparities affecting ethnic minorities
por: Morales, Daniel R, et al.
Publicado: (2021)

Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access
por: Phelan, Alexandra L, et al.
Publicado: (2020)

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition
por: Vuorio, Alpo, et al.
Publicado: (2021)

Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
Publicado: (2021)

Vitamin D for COVID-19: where are we now?
por: Martineau, Adrian R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mmrp8tvhqqm31suomtc7nitvk1